Clinical Trial Update: A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)

View source ↗

Summary

This clinical trial update describes a study evaluating the effect of BRIUMVI (ublituximab) on pregnancy and infant outcomes in people with multiple sclerosis, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• BRIUMVI (ublituximab)

Snippet

Sponsor: TG Therapeutics, Inc. | Conditions: Multiple Sclerosis | Status: RECRUITING